Fig 3 - available via license: CC BY-NC-ND
Content may be subject to copyright.
– (a) Medial sural perforator artery, (b) immediate post-operative reconstruction and (c) postoperative follow up, good cosmetic outcome with a medial sural perforator flap and no recurrence.
Context in source publication
Context 1
... was treated with hemiglossectomy. It was reconstructed with a medial sural perforator flap, and no neck dissection was performed on March of 2015 ( Fig. 3a-c). The patient had a good functional and cosmetic result with no signs of recurrence in subsequent follow-ups, last one on July 2016. ...
Similar publications
Leiomyosarcoma (LMS) of the inferior vena cava (IVC) is a rare malignant tumor, accounting for 2% of all LMSs. Less than 400 cases have been reported in literature. Computed tomography (CT) is the most accurate imaging method in assessing the location of the tumor within the IVC and magnetic resonance imaging (MRI) accurately identifies its extent...
Leiomyosarcoma (LMS) accounts for approximately 5-10% of soft tissue sarcomas, with an estimated incidence in the United States (US) of less than one case/200,000 persons, more frequent in women than men. Approximately two-thirds of LMSs are retroperitoneal, abdominal, and mediastinal. Localized, soft tissue LMSs represent a lower percentage, with...
Simple Summary
Pazopanib is an oral drug for metastatic pretreated uterine leiomyosarcoma that received approval in 2012, but poor data have been reported on its activity in real life since the disease is very rare. Uterine leiomyosarcoma has a poor objective response rate to other agents. We assessed the effectiveness and safety of pazopanib in ev...
